Adherence to pharmacologic management of hypertension.
Adherence to pharmacologic therapy of hypertension is low (in the range of 50-70%) and has important implications both for blood pressure control and cardiovascular complications. Based on a review of the literature using the levels of evidence grading technique, determinants of adherence to the pharmacologic therapy of hypertension have been assessed. Additionally, interventions to improve compliance were evaluated. Patient-centred, health care provider-centred and drug-specific factors have all been shown to affect adherence rates. We conclude that the extent of adherence to pharmacologic therapy is modifiable. Measurable improvements in adherence can be obtained from simplified medication regimens and a combination of behaviour strategies, including the tailoring of pill-taking to patients' daily habits and rituals, the advocacy of self-monitoring of pills and blood pressure, and the institution of reward systems.
Feldman
R
R
Department of Medicine, University of Western Ontario, London. feldmanr@lhsc.on.ca
Bacher
M
M
Campbell
N
N
Drover
A
A
Chockalingam
A
A
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D010349:Patient Compliance; D010353:Patient Education as Topic; D012648:Self Care
D000959:Antihypertensive Agents